Levcromakalim
Aura
Danish Headache CenterN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Aura cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
CL-H1T Charleston Laboratories, Inc | Phase 2 | B |
Prochlorperazine Alexza Pharmaceuticals, Inc. | Phase 2 | B |
Inhaled Pcz Alexza Pharmaceuticals, Inc. | Phase 2 | B |
Treximet® Danish Headache Center | Phase 2 | B |
Promethazine Charleston Laboratories, Inc | Phase 2 | B |
Same molecule, other indications
Levcromakalim is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →